AMRN Quote, Financials, Valuation and Earnings

Jazz Pharmaceuticals PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of 17.56%. Amarin Corp PLC's return on equity of -15.41% beat Jazz Pharmaceuticals PLC's return on equity of 14.39%.

Amarin Corp PLC has a consensus price target of $13.50, signalling upside risk potential of 29.43%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $192.22 which suggests that it could grow by 73.49%. Given that Jazz Pharmaceuticals PLC has higher upside potential than Amarin Corp PLC, analysts believe Jazz Pharmaceuticals PLC is more attractive than Amarin Corp PLC.

Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.419, suggesting its less volatile than the S&P 500 by 58.096%.

Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.

Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Jazz Pharmaceuticals PLC quarterly revenues of $1.1B. Amarin Corp PLC's net income of -$48.6M is lower than Jazz Pharmaceuticals PLC's net income of $191.1M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 12.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.94x versus 1.75x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.

Medtronic PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of 15.61%. Amarin Corp PLC's return on equity of -15.41% beat Medtronic PLC's return on equity of 8.56%.

Amarin Corp PLC has a consensus price target of $13.50, signalling upside risk potential of 29.43%. On the other hand Medtronic PLC has an analysts' consensus of $96.83 which suggests that it could grow by 15.06%. Given that Amarin Corp PLC has higher upside potential than Medtronic PLC, analysts believe Amarin Corp PLC is more attractive than Medtronic PLC.

Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.554%.

Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medtronic PLC offers a yield of 3.33% to investors and pays a quarterly dividend of $0.70 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Medtronic PLC pays out 99.73% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Medtronic PLC quarterly revenues of $8.3B. Amarin Corp PLC's net income of -$48.6M is lower than Medtronic PLC's net income of $1.3B. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 25.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.94x versus 3.29x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.

NuCana PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of --. Amarin Corp PLC's return on equity of -15.41% beat NuCana PLC's return on equity of --.

Amarin Corp PLC has a consensus price target of $13.50, signalling upside risk potential of 29.43%. On the other hand NuCana PLC has an analysts' consensus of $104.00 which suggests that it could grow by 18805.65%. Given that NuCana PLC has higher upside potential than Amarin Corp PLC, analysts believe NuCana PLC is more attractive than Amarin Corp PLC.

Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison NuCana PLC has a beta of 1.464, suggesting its more volatile than the S&P 500 by 46.355%.

Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NuCana PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amarin Corp PLC pays -- of its earnings as a dividend. NuCana PLC pays out -- of its earnings as a dividend.

Amarin Corp PLC quarterly revenues are $62.3M, which are larger than NuCana PLC quarterly revenues of --. Amarin Corp PLC's net income of -$48.6M is lower than NuCana PLC's net income of -$836.1K. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while NuCana PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.94x versus -- for NuCana PLC. Usually stocks with elevated PS ratios are considered overvalued.

Perrigo Co PLC has a net margin of -78.03% compared to Amarin Corp PLC's net margin of -3.91%. Amarin Corp PLC's return on equity of -15.41% beat Perrigo Co PLC's return on equity of -3.76%.

Amarin Corp PLC has a consensus price target of $13.50, signalling upside risk potential of 29.43%. On the other hand Perrigo Co PLC has an analysts' consensus of $34.60 which suggests that it could grow by 37.19%. Given that Perrigo Co PLC has higher upside potential than Amarin Corp PLC, analysts believe Perrigo Co PLC is more attractive than Amarin Corp PLC.

Amarin Corp PLC has a beta of 1.384, which suggesting that the stock is 38.378% more volatile than S&P 500. In comparison Perrigo Co PLC has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.326%.

Amarin Corp PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perrigo Co PLC offers a yield of 4.43% to investors and pays a quarterly dividend of $0.29 per share. Amarin Corp PLC pays -- of its earnings as a dividend. Perrigo Co PLC pays out -88.77% of its earnings as a dividend.

Amarin Corp PLC quarterly revenues are $62.3M, which are smaller than Perrigo Co PLC quarterly revenues of $1.1B. Amarin Corp PLC's net income of -$48.6M is lower than Perrigo Co PLC's net income of -$44.5M. Notably, Amarin Corp PLC's price-to-earnings ratio is -- while Perrigo Co PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amarin Corp PLC is 0.94x versus 0.79x for Perrigo Co PLC. Usually stocks with elevated PS ratios are considered overvalued.